Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07278401

Community Pharmacies as Social Determinant of Health Navigators

Type 1 hybrid effectiveness-implementation study using a quasi-experimental, difference-in-difference (DID) design to deliver a comprehensive social needs screening and navigation program by integrating Community Health Workers (CHWs) into community pharmacies across under-resourced areas in Western New York (WNY).

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Social Needs Status

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Black Rock Pharmacy, Buffalo, New York, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult subjects ≥ 18 years
  • English speaking
  • Presenting to one of the participating pharmacies. For the pharmacies to be included, they must be enrolled within the Community Pharmacy Enhanced Services Network - NY (CPESN-NY) or associated with Tops Pharmacies. The pharmacies must have the ability to collaborate with Healthelink and referring partners (e.g., Wellconnected) and the staffing capacity to have a SDoH screening program with Community Health Worker Training. The pharmacies' physical address must be located within Erie County

Exclusion criteria

  • Subjects ≤ 18 years

Treatment and study plan

Social needs screenings and referrals

Other

Community pharmacies will distribute social needs screening surveys to patients and refer them to local community based organizations based off of identified needs.

Primary outcomes

  1. Effectiveness Outcomes

    Time frame: 12 months

    Primary effectiveness outcomes in composite healthcare utilization including hospital admissions and ED visits at 12 months, and we hypothesize that utilization will be reduced in subjects who receive a pharmacy social needs intervention.

Secondary outcomes

  1. Cost Analysis

    Time frame: 12 months

    We will calculate interventions costs combined with cost savings from reduced utilization to calculate the net costs from a health system perspective.

Study contacts

Contact information is provided by the study sponsor or research team.

Christopher Daly

CONTACT

[email protected]

716-645-2828

David Jacobs

CONTACT

[email protected]

716-829-2134

Sponsors and collaborators

Lead sponsor

State University of New York at Buffalo

Other

Collaborators

  • CPESN-NY Pharmacies
  • National Center for Advancing Translational Sciences (NCATS)
  • Tops Pharmacies

Registry information

Acronym: SDoH

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Dec 12, 2025
Registry last updated
Dec 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.